Gene therapies continue to dominate pipeline for retinitis pigmentosa

20 June 2020 (Last Updated June 22nd, 2020 07:18)

A team of scientists at Trinity College Dublin and University College London recently posted a publication demonstrating how gene therapy can prevent the degeneration characteristic of retinitis pigmentosa involving the use of 3D retinal organoids serving as templates of human retinal disease.

Study results highlight the promise of gene therapies for people with inherited retinal diseases. Read more here.